Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qianhao Meng
Observed name:
Meng, Qianhao
Institutions:
Third Affiliated Hospital of Harbin Medical University,
Pudong New Area People's Hospital
Observed institutions:
Harbin Medical University,
Third Affiliated Hospital of Harbin Medical University,
Pudong New Area People's Hospital
ORCID:
0000-0003-1225-9004
Observed ORCID:
0000-0003-1225-9004
OpenAlex ID:
A5050733756
A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer
2023
·
Ke Wang
, Yuanyuan Yu
, et al.
·
Current Gene Therapy
·
18
Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study
2023
·
Qianhao Meng
, Jian Zhao
, et al.
·
BMC Cancer
·
6
PDF
The prognostic role of fasting plasma glucose levels on survival in advanced colorectal cancer patients with type II diabetes mellitus: a retrospective cohort study
2022
·
Qianhao Meng
, Yuanyuan Yu
, et al.
·
Journal of Gastrointestinal Oncology
·
6
PDF
Efficacy of Different Number of XELOX or SOX Chemotherapy Cycles After D2 Resection for Stage III Gastric Cancer
2022
·
Yuanyuan Yu
, Zicheng Zhang
, et al.
·
Journal of the Korean Gastric Cancer Association
·
4
Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
2021
·
Yuanyuan Yu
, Zicheng Zhang
, et al.
·
Frontiers in Oncology
·
3
PDF
A multicenter retrospective study of the combination of immune checkpoint inhibitors and chemotherapy regimens with or without liver metastasis for the first-line treatment of advanced gastric cancer
2024
·
Jing Ren
, Ke Wang
, et al.
·
Therapeutic Advances in Medical Oncology
·
2
Show more works
View as search
Works count:
8
Citation count:
39
H-index:
4
I10-index:
1
Year
Topic
Type